UTI vs LOPE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

UTI

46.2
AI Score
VS
LOPE Wins

LOPE

49.7
AI Score

Investment Advisor Scores

UTI

46score
Recommendation
HOLD

LOPE

50score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric UTI LOPE Winner
Forward P/E 27.248 13.2979 LOPE
PEG Ratio 1.8142 0.8865 LOPE
Revenue Growth 7.2% 6.7% UTI
Earnings Growth -78.9% 18.2% LOPE
Tradestie Score 46.2/100 49.7/100 LOPE
Profit Margin 3.9% 19.6% LOPE
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY LOPE

Relative Price Performance (Last 90 Days)

UTI 1M: -7.4% · 3M: -61.2% LOPE 1M: +4.1% · 3M: +1.5%

Current Technical Phase

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.9%), weak momentum, RSI 35

RSI (14): 34.9 · Price: $19.38

LOPE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 61

RSI (14): 61.1 · Price: $155.79

Fundamentals Snapshot

Metric UTI LOPE
Market Cap — —
Forward P/E 26.4 13.8
Trailing P/E 30.7 18.3
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.6% 0.5%
Operating Margin 0.0% 0.2%
EPS 0.62 8.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LOPE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.